Brief: Opsens Receives Approval From Health Canada To Initiate First In-Man Clinical Study For New Guidewire For TAVR Procedure
20/09/2021 12:32
Sept 20 (Reuters) - Opsens Inc OPS.TO :
* OPSENS RECEIVES APPROVAL FROM HEALTH CANADA TO INITIATE
FIRST
IN-MAN CLINICAL STUDY FOR ITS NEW GUIDEWIRE FOR TAVR PROCEDURE
Source text for Eikon: ID:nCNW3L3Wna
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe